One in 10 may have active virus after 10-day quarantine: study
By
Alicia Lasek
Jan 19, 2022
Fully 13% of study participants had clinically relevant levels of the SARS-CoV-2 virus after 10 days. The findings may be particularly concerning for vulnerable populations such as nursing facility residents,...
Health officials urge public to consider wearing N95, KN95 respirators
By
Alicia Lasek
Jan 19, 2022
The CDC has updated its consumer information on wearing face masks during the pandemic. The changes clarify levels of mask protection and emphasize that the public can choose to wear N95 and KN95 respirators...
Clinical briefs for Wednesday, Jan. 19
By
Alicia Lasek
Jan 19, 2022
OSHA vows to ‘hold businesses accountable’ after Supreme Court halts vaccine mandate for private companies … Free at-home COVID-19 tests offered via federal website starting today … Are EHR...
COVID-19 doubles seniors’ chances of reduced mobility, physical function: study
By
Alicia Lasek
Jan 17, 2022
The results suggest that older patients should be prioritized for rehab interventions with the goal of restoring functional mobility to pre-disease levels, investigators say.
Osteoporosis med ‘holiday’ may come with 18% higher risk of fracture
By
Alicia Lasek
Jan 18, 2022
Taking time off from certain bone health drugs is recommended after three to five years, but a hiatus from risedronate is tied to an increased risk of fracture among older adults, a new study finds.
Clinical briefs for Tuesday, Jan. 18
By
Alicia Lasek
Jan 18, 2022
CMS sets new vax deadlines for 24 states … Cognitive decline prevention guidelines for primary care published … Wearable badge detects exposure to COVID-19 … Breast cancer rates have declined in...
Nursing home clinicians still overdiagnose UTIs despite antibiotic stewardship efforts: study
By
Alicia Lasek
Jan 14, 2022
As a group, primary care providers and RNs misclassified UTIs about one-third of the time, an investigator tells McKnight’s. Nurses had greater odds of an incorrect assessment.
Supplies of groundbreaking COVID-19 pills Paxlovid, molnupiravir remain scarce
By
Alicia Lasek
Jan 14, 2022
U.S. clinicians may have to wait longer to receive a steady supply of highly anticipated COVID-19 antiviral pills as they manage the omicron variant surge.
Sotrovimab’s maker seeks okay for drug to be delivered by injection
By
Alicia Lasek
Jan 14, 2022
An easier administration method could be a big help to long-term care clinicians. Sotrovimab is currently the only monoclonal antibody treatment shown to be highly effective against the omicron variant.
Clinical briefs for Friday, Jan. 14
By
Alicia Lasek
Jan 14, 2022
Supreme Court says yea to CMS vaccine mandate, nay to OSHA’s version … Biden to deploy strike medical teams, allocate more rapid tests and N95 masks as omicron rages … CDC: Mask recommendations...